Trajan

Trajan Signs Agreement with GenTegra to Distribute RNA Stabilization Solution for Mitra-VAMS Microsampling

Retrieved on: 
Tuesday, November 28, 2023

PLEASANTON, Calif. and TORRANCE, Calif., Nov. 28, 2023 /PRNewswire-PRWeb/ -- Trajan Scientific and Medical (Trajan), a global developer and manufacturer of analytical and life sciences products, today announced they have signed an agreement with GenTegra, an innovator of biological sample protection solutions, to distribute the GenTegraRNA-NEO Active Chemical Protection™ technology. GenTegra's protection solution, designed exclusively for Trajan, can be applied to Trajan's Neoteryx Mitra® microsampling devices based on VAMS® technology for RNA-based studies. Once treated, the devices are intended to provide researchers with high-quality RNA recovery from remote blood microsamples that don't require cold-shipping or storage for up to 7 days before extraction. The GenTegraRNA-NEO technology protects against naturally occurring nucleases and environmental stresses that could degrade the RNA in blood samples.

Key Points: 
  • GenTegra's protection solution, designed exclusively for Trajan, can be applied to Trajan's Neoteryx Mitra® microsampling devices based on VAMS® technology for RNA-based studies.
  • "GenTegra is proud to collaborate with Trajan in introducing the GenTegraRNA-NEO Active Chemical Protection™ technology, exclusively tailored for Neoteryx Mitra® microsampling devices," said Robert (Bob) Barrett, President, GenTegra.
  • "GenTegra is proud to collaborate with Trajan in introducing the GenTegraRNA-NEO Active Chemical Protection™ technology, exclusively tailored for Neoteryx Mitra® microsampling devices," said Robert (Bob) Barrett, President, GenTegra.
  • "The overwhelmingly positive feedback from early users reinforces the impact of GenTegraRNA-NEO technology coupled with Mitra microsampling devices."

Metabolon Collaborates with Trajan on Microsampling Solutions for Metabolomics Research

Retrieved on: 
Monday, November 20, 2023

MORRISVILLE, N.C. and TORRANCE, Calif., Nov. 20, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, and Trajan Scientific and Medical, creator of Neoteryx Mitra® biological sample collection devices based on VAMS® technology, announce a partnership to collaborate on microsampling solutions for metabolomics research.   

Key Points: 
  • MORRISVILLE, N.C. and TORRANCE, Calif., Nov. 20, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, and Trajan Scientific and Medical, creator of Neoteryx Mitra® biological sample collection devices based on VAMS® technology, announce a partnership to collaborate on microsampling solutions for metabolomics research.
  • Life science research studies are frequently constrained by their inability to easily and efficiently secure adequate, stable biological samples.
  • Mitra devices offer precision via a volumetric absorptive microsampling method that is minimally invasive and user-friendly.
  • To learn more about metabolomics and how Metabolon is partnering with Trajan to take advantage of Neoteryx Mitra collection devices based on VAMS technology, please visit the Metabolon website or Neoteryx website .

Metabolon Collaborates with Trajan on Microsampling Solutions for Metabolomics Research

Retrieved on: 
Monday, November 20, 2023

MORRISVILLE, N.C. and TORRANCE, Calif., Nov. 20, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, and Trajan Scientific and Medical, creator of Neoteryx Mitra® biological sample collection devices based on VAMS® technology, announce a partnership to collaborate on microsampling solutions for metabolomics research.

Key Points: 
  • MORRISVILLE, N.C. and TORRANCE, Calif., Nov. 20, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, and Trajan Scientific and Medical, creator of Neoteryx Mitra® biological sample collection devices based on VAMS® technology, announce a partnership to collaborate on microsampling solutions for metabolomics research.
  • Life science research studies are frequently constrained by their inability to easily and efficiently secure adequate, stable biological samples.
  • Mitra devices offer precision via a volumetric absorptive microsampling method that is minimally invasive and user-friendly.
  • To learn more about metabolomics and how Metabolon is partnering with Trajan to take advantage of Neoteryx Mitra collection devices based on VAMS technology, please visit the Metabolon website or Neoteryx website .

Trajan's Microsampling Devices Meet IVDR Compliance in Europe, UK

Retrieved on: 
Friday, June 2, 2023

MELBOURNE, Australia, June 2, 2023 /PRNewswire/ -- Trajan Scientific and Medical, a leading provider of analytical and life sciences products and solutions, today announced the regulatory approval of its Neoteryx remote blood microsampling devices, Mitra® and hemaPEN® for clinical use in Europe and the United Kingdom.

Key Points: 
  • Trajan has successfully fulfilled the required product safety and performance requirements under the In Vitro Diagnostic Medical Devices Regulation (IVDR) in Europe and the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom.
  • Having earned this CE Mark regulatory compliance, Trajan expands the capabilities of its Neoteryx® microsampling products to provide decentralised, person-centered, minimally invasive blood collection in both clinical and research settings.
  • Mitra® and hemaPEN® devices can be used remotely to collect blood samples through an easy, virtually painless process.
  • "The updated regulatory approval of Trajan's blood microsampling devices in the UK and European Union is another step forward towards our vision of personalized, preventative data-based healthcare," said Stephen Tomisich, CEO and founder of Trajan.

Trajan's Microsampling Devices Meet IVDR Compliance in Europe, UK

Retrieved on: 
Friday, June 2, 2023

MELBOURNE, Australia, June 2, 2023 /PRNewswire/ -- Trajan Scientific and Medical, a leading provider of analytical and life sciences products and solutions, today announced the regulatory approval of its Neoteryx remote blood microsampling devices, Mitra® and hemaPEN® for clinical use in Europe and the United Kingdom.

Key Points: 
  • Trajan has successfully fulfilled the required product safety and performance requirements under the In Vitro Diagnostic Medical Devices Regulation (IVDR) in Europe and the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom.
  • Having earned this CE Mark regulatory compliance, Trajan expands the capabilities of its Neoteryx® microsampling products to provide decentralised, person-centered, minimally invasive blood collection in both clinical and research settings.
  • Mitra® and hemaPEN® devices can be used remotely to collect blood samples through an easy, virtually painless process.
  • "The updated regulatory approval of Trajan's blood microsampling devices in the UK and European Union is another step forward towards our vision of personalized, preventative data-based healthcare," said Stephen Tomisich, CEO and founder of Trajan.

Boston University's Pregnancy Study Online (PRESTO) Expands with Remote Microsampling by Trajan

Retrieved on: 
Monday, March 6, 2023

BOSTON and LOS ANGELES, March 6, 2023 /PRNewswire-PRWeb/ -- The Pregnancy Study Online (PRESTO) at Boston University, which investigates environmental influences on fertility and miscarriage, expanded its protocol this year to offer at-home biospecimen collection to participants across 48 states. The PRESTO research team is conducting a sub-study called the Environmental Pregnancy Study Online (E-PRESTO), using biospecimen analysis to learn if certain chemicals in the environment are harmful to reproductive health. To encourage participation of couples across a wider geographical area, the researchers are offering a mail-based E-PRESTO option, shipping sampling kits to participants' homes. Trajan's Mitra® devices are included in the mailed kits for remote self-collection of blood samples using a quick finger-prick method. The kits also include collection cups to facilitate urine collection at home. All samples are mailed back to BU for storage and analysis at various external laboratories over the next 2 years. After analysis, participants receive a report of their exposure to chemicals and how to reduce exposure levels.

Key Points: 
  • The PRESTO research team is conducting a sub-study called the Environmental Pregnancy Study Online (E-PRESTO), using biospecimen analysis to learn if certain chemicals in the environment are harmful to reproductive health.
  • Trajan's Mitra® devices are included in the mailed kits for remote self-collection of blood samples using a quick finger-prick method.
  • The E-PRESTO researchers encourage study participants in the Boston or Detroit areas to participate in traditional venipuncture blood draws in their respective clinics.
  • To enroll in PRESTO & E-PRESTO, click on the study invitation link or contact the BU research team at: [email protected] or 617-358-3424.

Neoteryx Provides Microsampling Devices to Fianostics for COVID-19 Antibody Tests in Austria

Retrieved on: 
Monday, October 31, 2022

LOS ANGELES and WIENER NEUSTADT, Austria, Oct. 31, 2022 /PRNewswire/ -- Fianostics GmbH in Austria has launched new COVID-19 antibody test kits that include Mitra devices from Neoteryx, the microsampling brand of Trajan Scientific and Medical.

Key Points: 
  • LOS ANGELES and WIENER NEUSTADT, Austria, Oct. 31, 2022 /PRNewswire/ -- Fianostics GmbH in Austria has launched new COVID-19 antibody test kits that include Mitra devices from Neoteryx, the microsampling brand of Trajan Scientific and Medical.
  • The new COVID-19 kits from Fianostics work in tandem with their FluoBolt-DUO SN Antibody Test, combined with capillary blood microsamples collected on Mitra devices for detection of SARS-CoV-2 antibodies.
  • The FluoBolt-DUO SN Antibody Test Kits from Fianostics are provided at select pharmacies within Austria.
  • The FluoBolt-DUO SN Antibody Test Kits are registered for use by trained personnel, but consumers don't need a physician's authorization to purchase them.

Neoteryx Launches Program to Support Microsampling Pilot Studies

Retrieved on: 
Monday, September 26, 2022

LOS ANGELES, Sept. 26, 2022 /PRNewswire/ -- Neoteryx, a brand of Trajan Scientific and Medical that provides remote specimen collection and microsampling devices to research and healthcare organizations, launches a new Research Support Program. The program provides free Mitra® microsampling devices as "in-kind" gifts to enable scientists to apply remote blood collection and microsampling in novel studies. This program provides an opportunity to determine the feasibility of remote sampling approaches in different environments. Selected research candidates will be awarded microsampling devices for pilot studies that have the greatest potential to positively impact human health and wellbeing. 

Key Points: 
  • LOS ANGELES, Sept. 26, 2022 /PRNewswire/ -- Neoteryx, a brand of Trajan Scientific and Medical that provides remote specimen collection and microsampling devices to research and healthcare organizations, launches a new Research Support Program.
  • The program provides free Mitra microsampling devices as "in-kind" gifts to enable scientists to apply remote blood collection and microsampling in novel studies.
  • Selected research candidates will be awarded microsampling devices for pilot studies that have the greatest potential to positively impact human health and wellbeing.
  • The Research Support Program is open to applicants pursuing new microsampling projects in academic research, medical research, public health, or scientific field studies in a range of geographies.

Trajan to acquire leading chromatography consumables and tools business building critical mass in the gas chromatography portfolio

Retrieved on: 
Sunday, June 19, 2022

MELBOURNE, Australia, June 19, 2022 /PRNewswire/ -- Global analytical science and device company Trajan Group Holdings Limited (ASX: TRJ) (Trajan or the Company) has today announced the signing of a binding share purchase agreement and a real estate purchase agreement to acquire 100% of Chromatography Research Supplies, Inc. (CRS), a leading global manufacturer of high-quality analytical consumables based in Kentucky, USA.

Key Points: 
  • Trajan to acquire Chromatography Research Supplies, Inc. (CRS), a leading global manufacturer of high-quality analytical consumables
    Provides Trajan with enhanced and extended production capabilities to service its growing gas chromatography business.
  • Strengthens Trajan's product portfolio particularly in the critical area of the gas chromatography inlet and sample introduction
    Investor webinar to be held at 10:30am (AEST) Friday 17thJune 2022.
  • Having operated for over 25 years, CRS is a leading manufacturer of electronic and manual crimping tools, gas filters, ferrules, and injection port septa.
  • CRS has been a long-term supplier of consumables to Trajan since Trajan's acquisition of SGE Analytical in 2013.

Trajan to acquire leading chromatography consumables and tools business building critical mass in the gas chromatography portfolio

Retrieved on: 
Friday, June 17, 2022

MELBOURNE, Australia, June 17, 2022 /PRNewswire/ -- Global analytical science and device company Trajan Group Holdings Limited (ASX: TRJ) (Trajan or the Company) has today announced the signing of a binding share purchase agreement and a real estate purchase agreement to acquire 100% of Chromatography Research Supplies, Inc. (CRS), a leading global manufacturer of high-quality analytical consumables based in Kentucky, USA.

Key Points: 
  • Trajan to acquire Chromatography Research Supplies, Inc. (CRS), a leading global manufacturer of high-quality analytical consumables
    Provides Trajan with enhanced and extended production capabilities to service its growing gas chromatography business.
  • Strengthens Trajan's product portfolio particularly in the critical area of the gas chromatography inlet and sample introduction
    Investor webinar to be held at 10:30am (AEST) Friday 17thJune 2022.
  • Having operated for over 25 years, CRS is a leading manufacturer of electronic and manual crimping tools, gas filters, ferrules, and injection port septa.
  • CRS has been a long-term supplier of consumables to Trajan since Trajan's acquisition of SGE Analytical in 2013.